+63.6%
CVS vs EXEL
+160.6%
-97.0%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EXEL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -2.3% | +1.6% | -0.4% |
| 7D | -1.6% | +1.4% | -2.9% | -1.7% |
| 30D | +0.4% | +6.7% | -6.3% | -0.4% |
| 3M | -0.4% | +11.5% | -11.9% | -1.7% |
| 6M | +25.1% | +38.8% | -13.7% | +21.0% |
| YTD | +23.9% | +31.6% | -7.7% | +20.1% |
| 1Y | +41.1% | +53.0% | -11.9% | +34.7% |
| 3Y | +63.6% | +160.8% | -97.2% | +46.0% |
| All | +63.6% | +160.6% | -97.0% | +46.0% |
Cumulative growth
Daily Returns
Daily percentage return beside EXEL.
Daily Out/Under-Performance
Portfolio return minus EXEL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXEL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EXEL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling